Partner Network for a Clinically Validated Multi-Analyte Lab-on-a-Chip Platform (PARCIVAL)


At a Glance
  • Status: Completed Consortium
  • Year Launched: 2012
  • Initiating Organization: European Commission Seventh Framework Programme (FP7)
  • Initiator Type: Government
  • No disease focus
  • Location: Europe

Abstract

The objective of Partner Network for a Clinically Validated Multi-Analyte Lab-on-a-Chip Platform (PARCIVAL) is to develop an integrated and automated multi-analyte lab-on-a-disk platform for the fast and reliable “sample in-answer out” diagnosis of highly infectious respiratory pathogens, resistance patterns, and biomarkers for individual severity of the infection.

Mission

The objective of PARCIVAL is to develop an integrated and automated multi-analyte lab-on-a-disk platform for the fast and reliable sample in-answer out diagnosis of highly infectious respiratory pathogens, resistance patterns, and biomarkers for individual severity of the infection. The platform format will be based on completely integrated microfluidic foil-disposables. The disposables will feature different panels (selection of pathogens, resistance patterns, biomarkers), which can be freely selected and combined to allow a comprehensive choice of diagnostic parameters by the clinician at the point-of-care, vastly increasing the access to diagnostic information for doctors in everyday situations and emergencies. The integrated platform with pre-packaged liquid and dry reagents will automate all processing steps from sample preparation to assay processing to result reporting. This will allow evidence-based therapeutic decisions and allow antibiotic prescriptions that are tailored to the individual patient and thus offer the prospect to greatly improve therapeutic outcomes. Also, an air-sampling add-on module for monitoring of clinical ventilation systems will be developed and interfaced to the platform.

Consortium History

The project started on Jan. 1 2012, and lasted for three years.

Structure & Governance

The consortium consists of nine partners (six enterprises, four of which are SMEs, and three institutes).

Sponsors & Partners

PARCIVAL is a project financed by the EC (FP7-HEALTH Collaborative project).

Homepage

http://www.parcival-project.eu/

e-mail: info@parcival-project.eu

Erasmus University Medical Centre

HAHN-Schickard Society for Applied Research

Institutul National De Cercetaredezvoltare Pentru Microtehnologie

Medizinisches Versorgungszentrum – Labor Stein (Germany)

PathoFinder (Netherlands)

Rohrer Switzerland

Askion

Agrobiogen (Germany)

Germany GMBH EADS


Last Updated: 04/15/2016

The Consortia-pedia Catalogue is a living resource, and we are always adding new consortia. Provide information here about your collaboration to apply to be included in the Catalogue.

All the information contained in the Consortia-pedia was collected from publically available sources. Decisions to include or exclude a particular listing from Consortia-pedia were also made on the basis of publically available information and the criteria outlined in the FAQs. This site is intended to be an objective resource for the community, and inclusion does not constitute or imply endorsement, recommendation, or approval by FasterCures or the Milken Institute.